about
Solution structure of Rv2377c-founding member of the MbtH-like protein familyInaugural structure from the DUF3349 superfamily of proteins, Mycobacterium tuberculosis Rv0543cSolution-state NMR structure and biophysical characterization of zinc-substituted rubredoxin B (Rv3250c) from Mycobacterium tuberculosisUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Extensively drug-resistant Mycobacterium tuberculosis from aspirates, Rural South Africa.Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.CD8+ DC, but Not CD8(-)DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection.Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.Cisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria.Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NConsistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician's nightmare.Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium.Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.A Case of Disseminated Multidrug-Resistant Tuberculosis involving the Brain.Problems in diagnosis and treatment of tuberculosis infectionThe Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.Drug-susceptibility testing in TB: current status and future prospects.Modification of proportion sensitivity testing method for ethionamide.[Multiresistant tuberculosis in Brazil: history and control].Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.Cell response of Escherichia coli to cisplatin-induced stress.A rapid culture system uninfluenced by an inoculum effect increases reliability and convenience for drug susceptibility testing of Mycobacterium tuberculosis.
P2860
Q27661119-B1DA69A4-0D0E-4B6C-922E-9866F774AAC6Q27666231-83CC01D1-91B5-47BB-B123-3F3BEBC23EEEQ27673638-2BF27E49-CA34-4451-BEC2-A4973BC57939Q28265803-DBE1F157-A9FC-4883-8373-260A92166971Q30427302-9EC51BCE-16AC-44ED-90F3-364189B0D985Q30433414-B31CD415-DABA-46DC-BA8D-433206177DC9Q30433540-530AF7CE-2FDB-4EA0-8F81-E5CC4B94E9E1Q33533344-CF7521F9-01F5-44D5-9433-F3D07F449813Q34201423-024BF40D-EFA9-4936-B1EB-A9D15403E82FQ34488965-2627084C-0950-42AF-B1BA-D3DC35255A77Q34924586-0A3FB1AE-A63F-44DF-A301-6876B037DA74Q36107644-468D5CEE-80E0-4BE2-9BA5-885FB0E53558Q36402705-FB808C67-C0E1-43D6-825A-06BF542DAEBFQ36550144-F5E8A002-7177-4037-A0A7-00441D33E474Q36550160-C2D71B62-53EF-43C3-8F88-864E5B41175BQ36773017-EAB1D02D-44F1-42E9-B648-9EC242954DE5Q36809127-37B8103C-EE5A-4821-BC7A-363C1EB2EF5AQ37078271-09FA4F0E-0CA1-4EE2-AA23-84E51F12CAA3Q37107614-75B5E004-9C14-4C6B-B68A-3B23E8523C8FQ38097123-8E2EC936-B582-441D-9CEC-C5A1142DF3FDQ39218265-D8CD190E-425B-4A3D-AD2E-6324083C4054Q39872573-91494DC9-680E-48B4-BDCA-E3E299553C75Q45186615-BD989F09-608A-4E44-B488-FB5C2338E405Q46882513-324BF94C-8E07-4222-ABF7-DE8D4B13BE4BQ51542242-037CC6D8-48B6-44BD-85C7-3B1D97BC1B3DQ54351595-C669CD59-777F-4996-BCCE-D54A9431E1B9Q55227253-4471B3EB-41DE-48A0-8932-81DB0AAEAC72
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Drug resistance in tuberculosis.
@ast
Drug resistance in tuberculosis.
@en
type
label
Drug resistance in tuberculosis.
@ast
Drug resistance in tuberculosis.
@en
prefLabel
Drug resistance in tuberculosis.
@ast
Drug resistance in tuberculosis.
@en
P1476
Drug resistance in tuberculosis.
@en
P2093
D A Mitchison
P304
P356
10.1183/09031936.05.00075704
P577
2005-02-01T00:00:00Z